admin – Page 135 – Healthcare Data News

January 14, 2022January 17, 2022 Partner and Collaborator News RWE Study

Between the Lines™ Podcast: Incorporating Real-World Evidence into Clinical Decisions in NSCLC

Lyudmila Bazhenova, MD, and Federico Albrecht, MD, detailed the importance of using real-world evidence to inform treatment for patients with EGFR-mutated non–small cell lung cancer.https://embeds.audioboom.com/posts/8012579/embed/v4 As part of its Between...

January 14, 2022January 17, 2022 AI Competitor News Fundraising/IPO

Labour peer’s AI healthcare firm Sensyne says cash is running out

Data analytics company run by Paul Drayson says money could run out in weeks unless it finds emergency funding Julia KolleweFri 14 Jan 2022 13.55 EST Shares in Sensyne Health plummeted after...

January 14, 2022January 17, 2022 Competitor News Fundraising/IPO

Digital Health Leader Verana Health Secures $150M Series E Funding Round

SAN FRANCISCO, Jan. 14, 2022 /PRNewswire/ — Verana Health, a digital health company that delivers quality drug lifecycle and medical practice insights from an exclusive real-world data network, today announced a $150 million Series E...

January 14, 2022 Clinical Trials Competitor News

Tempus Announces Open Enrollment for Study in Collaboration with GSK to Evaluate Niraparib in Advanced Solid Tumor Patients with PALB2 Mutations

Tempus, a leader in artificial intelligence and precision medicine, today announced the commencement of an open label phase II study, in collaboration with GlaxoSmithKline (GSK) to evaluate the efficacy and...

January 14, 2022 Partner and Collaborator News Product Updates

Palantir Introduces Certification Program to Scale Platform and Empower Customers and Strategic Partners

The Palantir Certification Program will provide an opportunity for users to highlight their Foundry knowledge, skills, and abilities, while their employers will be able to accelerate their transformation by identifying...

January 13, 2022 Collaborations Competitor News Data Partnership Oncology

Skin-related side effects indicate better prognosis for patients taking certain cancer drugs

Immune checkpoint inhibitors, which strengthen the immune response against tumor cells, have become standard of care for many patients with advanced cancers; however, the medications can often cause side effects,...

January 13, 2022 Collaborations Competitor News

Maya and National Psychedelics Association Announce Partnership to Support Psilocybin-Assisted Services in Oregon

PORTLAND, ORE. (PRWEB) JANUARY 12, 2022 Today, Maya (Maya PBC) and the National Psychedelics Association (NPA) announced their partnership in support of the implementation of Oregon’s Measure 109, the first state-approved policy to allow the...

January 13, 2022 Collaborations Competitor News Product Updates

Proscia and Datavant Partner to Connect Pathology Data with Health Data Ecosystem for Life Sciences R&D

PHILADELPHIA and SAN FRANCISCO, Jan. 13, 2022 (GLOBE NEWSWIRE) — Proscia, the leader in digital and computational pathology solutions, and Datavant, the leader in helping organizations securely connect health data, today announced...

January 13, 2022January 17, 2022 Competitor News Fundraising/IPO

Alira Health Secures an Additional $40M in Funding, Led by Creadev

This investment accelerates Alira Health’s plan to deliver patient-centric, technology-enabled healthcare solutions. January 13, 2022 09:00 AM Eastern Standard Time FRAMINGHAM, Mass.–(BUSINESS WIRE)–Alira Health (www.alirahealth.com), a global technology-enabled healthcare consultancy,...

January 12, 2022 Competitor News HR

Curta announces the addition of expert health economists Sean D. Sullivan, Scott Ramsey, David Veenstra and Josh Carlson as partners in next stage of growth

SEATTLE, Jan. 12, 2022 /PRNewswire/ — Curta, a growing provider of health economics and outcomes research products and services, today announced that Sean D. Sullivan, BSPharm, PhD, Scott Ramsey, MD, PhD, David Veenstra, PharmD, PhD, and Josh...